Other Tracked since Q4 FY26 - Q4 FY26

Corona Remedies Ltd

CORONAREMEDIES

Latest quarter Q4 FY26

Revenue ₹353 Cr (+17.3% YoY)

Management credibility Building

Needs more scored promises across 1 quarters

Latest signal bullish

Corona Remedies delivered a strong FY26, with revenue of ₹1,403 Cr (+17.3% YoY) and PAT of ₹199 Cr (+33.4% YoY), exce...

Quarterly Earnings Timeline

Filing-verified financials, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q4 FY26 30 Apr 2026

Revenue ₹353 Cr (+17.3% YoY)

Corona Remedies delivered a strong FY26, with revenue of ₹1,403 Cr (+17.3% YoY) and PAT of ₹199 Cr (+33.4% YoY), exceeding guided ranges.